Harvard Bioscience (HBIO) Net Cash Flow Growth (5y) (2015 - 2026)
Harvard Bioscience (HBIO) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.91% |
| Mar 31, 2026 | 11.70% |
| Dec 31, 2025 | -20.53% |
| Sep 30, 2025 | -54.40% |
| Jun 30, 2025 | 19.07% |
| Mar 31, 2025 | 19.63% |
| Dec 31, 2024 | -15.70% |
| Sep 30, 2024 | -41.15% |
| Jun 30, 2024 | -9.18% |
| Mar 31, 2024 | 15.32% |
| Dec 31, 2023 | -20.52% |
| Sep 30, 2023 | 3.66% |
| Jun 30, 2023 | 105.67% |
| Mar 31, 2023 | -9.80% |
| Dec 31, 2022 | 28.94% |
| Sep 30, 2022 | -12.93% |
| Jun 30, 2022 | -55.29% |
| Mar 31, 2022 | -16.40% |
| Dec 31, 2021 | 10.80% |
| Sep 30, 2021 | -18.62% |